Innovative Eyewear (LUCY) director discloses December common stock buy

Rhea-AI Filing Summary

Innovative Eyewear Inc reported an insider stock purchase by director Vladimir Galkin. On 12/04/2025, he bought 2,507 shares of common stock at $1.5 per share in an open-market transaction classified as a purchase.

After this trade, Galkin beneficially owns 997,493 shares of Innovative Eyewear common stock. The filing explains that these shares are held jointly by Vladimir Galkin and his wife, Angelica Galkin, reflecting shared ownership within the household.

Insider Trade Summary

Net Buyer: 2,507 shares ($3,761)

Net Buy 1 txn

Insider Galkin Vladimir

Role 10% Owner

Bought 2,507 shs ($4K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.00001	2,507	$1.50	$4K

Holdings After Transaction: Common Stock, par value $0.00001 — 997,493 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/08/2025 - 12:35 PM Learn about SEC filing dates

FAQ

What insider transaction did Innovative Eyewear (LUCY) disclose in this filing?

The filing shows that director Vladimir Galkin purchased 2,507 shares of Innovative Eyewear common stock on 12/04/2025 at a price of $1.5 per share.

Who is the reporting person in the Innovative Eyewear (LUCY) Form 4 filing?

The reporting person is Vladimir Galkin, who is listed as a director of Innovative Eyewear Inc and filed the report as one reporting person.

How many Innovative Eyewear (LUCY) shares does the insider own after the reported trade?

Following the reported transaction, Vladimir Galkin beneficially owns 997,493 shares of Innovative Eyewear common stock.

How are Vladimir and Angelica Galkin's Innovative Eyewear (LUCY) shares held?

The explanation states that the shares of common stock are held jointly by Vladimir Galkin and Angelica Galkin, who are husband and wife.

Does this Innovative Eyewear (LUCY) filing report any derivative securities transactions?

No derivative securities are reported. The table for derivative securities is included but does not list any options, warrants, or other derivative positions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galkin Vladimir

(Last) (First) (Middle)

10900 N.W. 97TH. STREET, SUITE #102

(Street)

MIAMI FL 33178

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.00001	12/04/2025		P		2,507	D	$1.5	997,493	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

	Vladimir Galkin, Attorney in Fact	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.